Osteoprotegerin Reduces Osteoclast Numbers and Prevents Bone Erosion in Collagen-Induced Arthritis
- 1 October 2002
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 161 (4) , 1419-1427
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Osteoprotegerin ameliorates sciatic nerve crush induced bone lossJournal of Orthopaedic Research, 2001
- The final pathogenetic steps in focal bone erosions in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2000
- Osteoprotegerin mitigates tail suspension-induced osteopeniaBone, 2000
- RANKing the importance of measles virus in Paget’s diseaseJournal of Clinical Investigation, 2000
- Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritisArthritis & Rheumatism, 2000
- Activated T Lymphocytes Support Osteoclast Formation in VitroBiochemical and Biophysical Research Communications, 1999
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJournal of Clinical Investigation, 1999
- Hypocalcemic Effect of Osteoclastogenesis Inhibitory Factor/Osteoprotegerin in the Thyroparathyroidectomized RatEndocrinology, 1998
- Collagen-induced arthritis, an animal model of autoimmunityLife Sciences, 1997
- Human and Murine Osteocalcin Gene Expression: Conserved Tissue Restricted Expression and Divergent Responses to 1,25-Dihydroxyvitamin D3 in VivoMolecular Endocrinology, 1997